capeserod
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Serotonin 4 (5-HT4) receptorPARTIAL AGONIST
HTR4 partial agonist
Binds to other 5-HT receptors with micromolar affinity. Can't find any clinical trial IDs, only mentions that the compound has been through phase 2 trials (OTHER:http://en.wikipedia.org/wiki/SL65.0155).
Chemistry & pharmacology
Loading structure…
SMILES
Nc1c(Cl)cc(-c2nn(C3CCN(CCc4ccccc4)CC3)c(=O)o2)c2c1OCCO2- Mol. weight
- 456.93 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2027925 ↗
Also known as
- 5-(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-3-(1-(2-phenylethyl)-4-piperidinyl)-1,3,4-oxadiazol-2(3h)-one
- capeserod
- capeserod
- sl 65.0155
- sl-65.0155
- sl65.0155
- sl65.0155
- sl65.0155